Skip to main navigation Skip to search Skip to main content

Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON®) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: An open-label, multicentre, single-treatment-arm study

  • Gavin R. Graff
  • , John McNamara
  • , James Royall
  • , Steven Caras
  • , Kristin Forssmann

Research output: Contribution to journal › Article › peer-review

25   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON®) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: An open-label, multicentre, single-treatment-arm study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science